Robert P Thomen1, Laura L Walkup2, David J Roach2, Zackary I Cleveland3, John P Clancy4, Jason C Woods5. 1. Center for Pulmonary Imaging Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Department of Physics, Washington University in St. Louis, St. Louis, MO, United States. 2. Center for Pulmonary Imaging Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. 3. Center for Pulmonary Imaging Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Pulmonary Medicine, Cincinnati Children's Hospital, Cincinnati, OH, United States. 4. Division of Pulmonary Medicine, Cincinnati Children's Hospital, Cincinnati, OH, United States. 5. Center for Pulmonary Imaging Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Department of Physics, Washington University in St. Louis, St. Louis, MO, United States; Division of Pulmonary Medicine, Cincinnati Children's Hospital, Cincinnati, OH, United States. Electronic address: Jason.woods@cchmc.org.
Abstract
BACKGROUND: Cystic fibrosis (CF) is a genetic disease which carries high morbidity and mortality from lung-function decline. Monitoring disease progression and treatment response in young patients is desirable, but serial imaging via CT is often considered prohibitive, and detailed functional information cannot be obtained using conventional imaging techniques. Hyperpolarized 129Xe magnetic resonance imaging (MRI) can depict and quantify regional ventilation, but has not been investigated in pediatrics. We hypothesized that 129Xe MRI is feasible and would demonstrate ventilation defects in mild CF lung disease with greater sensitivity than FEV1. METHODS: 11 healthy controls (age 6-16years) and 11 patients with mild CF (age 8-16years, Forced Expiratory Volume (FEV1) percent predicted >70%) were recruited for this study. Nine CF patients had an FEV1>85%. Each subject was imaged via hyperpolarized 129Xe MRI, and the ventilation defect percentage (VDP) was measured. FEV1 and VDP were compared between the groups. RESULTS: FEV1 for controls was 100.3%±8.5% (mean±sd) and for CF patients was 97.9%±16.0% (p=0.67). VDP was 6.4%±2.8% for controls and 18.3%±8.6% for CF (p<0.001). When considering the 9 CF patients with normal FEV1 (>85%), the mean FEV1 was 103.1%±12.3% (p=0.57 compared to controls) and VDP was 15.4%±6.3% (p=0.002). CONCLUSIONS: Hyperpolarized 129Xe MRI demonstrated ventilation defects in CF patients with normal FEV1 and more effectively discriminated CF from controls than FEV1. Thus 129Xe may be a useful outcome measure to detect mild CF lung disease, to investigate regional lung function in pediatric lung diseases, and to follow disease progression.
BACKGROUND:Cystic fibrosis (CF) is a genetic disease which carries high morbidity and mortality from lung-function decline. Monitoring disease progression and treatment response in young patients is desirable, but serial imaging via CT is often considered prohibitive, and detailed functional information cannot be obtained using conventional imaging techniques. Hyperpolarized 129Xe magnetic resonance imaging (MRI) can depict and quantify regional ventilation, but has not been investigated in pediatrics. We hypothesized that 129Xe MRI is feasible and would demonstrate ventilation defects in mild CF lung disease with greater sensitivity than FEV1. METHODS: 11 healthy controls (age 6-16years) and 11 patients with mild CF (age 8-16years, Forced Expiratory Volume (FEV1) percent predicted >70%) were recruited for this study. Nine CFpatients had an FEV1>85%. Each subject was imaged via hyperpolarized 129Xe MRI, and the ventilation defect percentage (VDP) was measured. FEV1 and VDP were compared between the groups. RESULTS: FEV1 for controls was 100.3%±8.5% (mean±sd) and for CFpatients was 97.9%±16.0% (p=0.67). VDP was 6.4%±2.8% for controls and 18.3%±8.6% for CF (p<0.001). When considering the 9 CFpatients with normal FEV1 (>85%), the mean FEV1 was 103.1%±12.3% (p=0.57 compared to controls) and VDP was 15.4%±6.3% (p=0.002). CONCLUSIONS: Hyperpolarized 129Xe MRI demonstrated ventilation defects in CFpatients with normal FEV1 and more effectively discriminated CF from controls than FEV1. Thus 129Xe may be a useful outcome measure to detect mild CF lung disease, to investigate regional lung function in pediatric lung diseases, and to follow disease progression.
Authors: John P Mugler; Talissa A Altes; Iulian C Ruset; Isabel M Dregely; Jaime F Mata; G Wilson Miller; Stephen Ketel; Jeffrey Ketel; F William Hersman; Kai Ruppert Journal: Proc Natl Acad Sci U S A Date: 2010-11-22 Impact factor: 11.205
Authors: Colm J McMahon; Jonathan D Dodd; Catherine Hill; Neil Woodhouse; Jim M Wild; Stan Fichele; Charles G Gallagher; Stephen J Skehan; Edwin J R van Beek; James B Masterson Journal: Eur Radiol Date: 2006-07-27 Impact factor: 5.315
Authors: Miranda Kirby; Sarah Svenningsen; Hassaan Ahmed; Andrew Wheatley; Roya Etemad-Rezai; Nigel A M Paterson; Grace Parraga Journal: Acad Radiol Date: 2011-05-04 Impact factor: 3.173
Authors: Robert P Thomen; Ajay Sheshadri; James D Quirk; Jim Kozlowski; Henry D Ellison; Rhonda D Szczesniak; Mario Castro; Jason C Woods Journal: Radiology Date: 2014-08-19 Impact factor: 11.105
Authors: Bastiaan Driehuys; Santiago Martinez-Jimenez; Zackary I Cleveland; Gregory M Metz; Denise M Beaver; John C Nouls; S Sivaram Kaushik; Rafael Firszt; Christine Willis; Kevin T Kelly; Jan Wolber; Monica Kraft; H Page McAdams Journal: Radiology Date: 2011-11-04 Impact factor: 11.105
Authors: Panos Koumellis; Edwin J R van Beek; Neil Woodhouse; Stan Fichele; Andrew J Swift; Martyn N J Paley; Catherine Hill; Chris J Taylor; Jim M Wild Journal: J Magn Reson Imaging Date: 2005-09 Impact factor: 4.813
Authors: Brian O'Sullivan; Marcus Couch; John P Roche; Ronn Walvick; Shaokuan Zheng; Dawn Baker; Mac Johnson; Martyn Botfield; Mitchell S Albert Journal: Acad Radiol Date: 2014-08-27 Impact factor: 3.173
Authors: Laurie Smith; Helen Marshall; Ina Aldag; Felix Horn; Guilhem Collier; David Hughes; Noreen West; Alex Horsley; Chris J Taylor; Jim Wild Journal: Am J Respir Crit Care Med Date: 2018-02-01 Impact factor: 21.405
Authors: Marcus J Couch; Robert Thomen; Nikhil Kanhere; Raymond Hu; Felix Ratjen; Jason Woods; Giles Santyr Journal: J Cyst Fibros Date: 2019-03-25 Impact factor: 5.482
Authors: Robert P Thomen; Laura L Walkup; David J Roach; Nara Higano; Andrew Schapiro; Alan Brody; John P Clancy; Zackary I Cleveland; Jason C Woods Journal: Am J Respir Crit Care Med Date: 2020-07-15 Impact factor: 21.405
Authors: Laura L Walkup; Kasiani Myers; Javier El-Bietar; Adam Nelson; Matthew M Willmering; Michael Grimley; Stella M Davies; Christopher Towe; Jason C Woods Journal: Eur Respir J Date: 2019-05-02 Impact factor: 16.671
Authors: Lukas Ebner; Jeff Kammerman; Bastiaan Driehuys; Mark L Schiebler; Robert V Cadman; Sean B Fain Journal: Eur J Radiol Date: 2016-09-16 Impact factor: 3.528
Authors: Jennifer L Goralski; Sang Hun Chung; Tyler M Glass; Agathe S Ceppe; Esther O Akinnagbe-Zusterzeel; Aaron T Trimble; Richard C Boucher; Brian J Soher; H Cecil Charles; Scott H Donaldson; Yueh Z Lee Journal: JCI Insight Date: 2020-01-30
Authors: Alexei V Ouriadov; Matthew S Fox; Andras A Lindenmaier; Elaine Stirrat; Hacene Serrai; Giles Santyr Journal: MAGMA Date: 2020-07-06 Impact factor: 2.310